Home
>
National Drug Code (NDC)
>
REVALESKIN
REVALESKIN - 0145-2810-61 - (octinoxate and oxybenzone)
Drug Information of REVALESKIN
| Product NDC: | 0145-2810 |
| Proprietary Name: | REVALESKIN |
| Non Proprietary Name: | octinoxate and oxybenzone |
| Active Ingredient(s): | 75; 40 mg/mL; mg/mL & nbsp; octinoxate and oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of REVALESKIN
| Product NDC: | 0145-2810 |
| Labeler Name: | Stiefel Laboratories Inc |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20110429 |
Package Information of REVALESKIN
| Package NDC: | 0145-2810-61 |
| Package Description: | 1 BOTTLE in 1 CARTON (0145-2810-61) > 50 mL in 1 BOTTLE |
NDC Information of REVALESKIN
| NDC Code | 0145-2810-61 |
| Proprietary Name | REVALESKIN |
| Package Description | 1 BOTTLE in 1 CARTON (0145-2810-61) > 50 mL in 1 BOTTLE |
| Product NDC | 0145-2810 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | octinoxate and oxybenzone |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20110429 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Stiefel Laboratories Inc |
| Substance Name | OCTINOXATE; OXYBENZONE |
| Strength Number | 75; 40 |
| Strength Unit | mg/mL; mg/mL |
| Pharmaceutical Classes |
